IRF2BPL
Basic information
Region (hg38): 14:77024543-77028708
Previous symbols: [ "C14orf4" ]
Links
Phenotypes
GenCC
Source:
- neurodevelopmental disorder with regression, abnormal movements, loss of speech, and seizures (Moderate), mode of inheritance: AD
- neurodevelopmental disorder with regression, abnormal movements, loss of speech, and seizures (Strong), mode of inheritance: AD
- neurodegenerative disease (Definitive), mode of inheritance: AD
Clinical Genomic Database
Source:
Condition | Inheritance | Intervention Categories | Intervention/Rationale | Manifestation Categories | References |
---|---|---|---|---|---|
Neurodevelopmental disorder with regression, abnormal movements, loss of speech, and seizures | AD | General | Genetic knowledge may be beneficial related to issues such as selection of optimal supportive care, informed medical decision-making, prognostic considerations, and avoidance of unnecessary testing | Neurologic | 30057031 |
ClinVar
This is a list of variants' phenotypes submitted to
- not provided (11 variants)
- Neurodevelopmental disorder with regression, abnormal movements, loss of speech, and seizures (10 variants)
- Inborn genetic diseases (2 variants)
- Autism spectrum disorder (1 variants)
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the IRF2BPL gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 52 | 58 | ||||
missense | 136 | 16 | 156 | |||
nonsense | 13 | 19 | ||||
start loss | 0 | |||||
frameshift | 17 | 17 | 38 | |||
inframe indel | 15 | 17 | 10 | 42 | ||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 0 | |||||
non coding | 1 | |||||
Total | 22 | 34 | 156 | 86 | 16 |
Variants in IRF2BPL
This is a list of pathogenic ClinVar variants found in the IRF2BPL region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
14-77025406-G-A | IRF2BPL-related disorder | Uncertain significance (Aug 04, 2023) | ||
14-77025413-TCTC-T | Uncertain significance (Nov 22, 2022) | |||
14-77025439-G-A | Inborn genetic diseases | Uncertain significance (Jun 01, 2023) | ||
14-77025448-G-A | Uncertain significance (Dec 18, 2019) | |||
14-77025484-T-C | Uncertain significance (Mar 10, 2020) | |||
14-77025494-C-G | IRF2BPL-related disorder • Inborn genetic diseases | Uncertain significance (Aug 09, 2021) | ||
14-77025505-T-C | Inborn genetic diseases | Uncertain significance (Feb 05, 2024) | ||
14-77025531-G-T | Likely benign (Feb 01, 2024) | |||
14-77025555-ACT-A | Likely pathogenic (Aug 01, 2019) | |||
14-77025571-G-C | Uncertain significance (Feb 09, 2024) | |||
14-77025573-G-A | Likely benign (Sep 01, 2023) | |||
14-77025587-G-T | Uncertain significance (Feb 22, 2024) | |||
14-77025589-C-A | Rare genetic intellectual disability | Uncertain significance (-) | ||
14-77025590-T-A | IRF2BPL-related disorder | Likely benign (Jul 01, 2024) | ||
14-77025593-G-A | Neurodevelopmental disorder with regression, abnormal movements, loss of speech, and seizures • IRF2BPL-related disorder | Uncertain significance (Sep 17, 2023) | ||
14-77025596-C-A | Uncertain significance (Dec 18, 2023) | |||
14-77025632-GT-G | Neurodevelopmental disorder with regression, abnormal movements, loss of speech, and seizures | Pathogenic (Nov 29, 2022) | ||
14-77025640-CA-C | Inborn genetic diseases | Likely pathogenic (Nov 14, 2017) | ||
14-77025654-GA-G | Pathogenic (Dec 01, 2020) | |||
14-77025655-AG-A | Neurodevelopmental disorder with regression, abnormal movements, loss of speech, and seizures | Likely pathogenic (Aug 25, 2022) | ||
14-77025655-A-AGG | Neurodevelopmental disorder with regression, abnormal movements, loss of speech, and seizures | Likely pathogenic (Sep 27, 2022) | ||
14-77025657-G-GAC | Neurodevelopmental disorder with regression, abnormal movements, loss of speech, and seizures | Pathogenic (Jul 02, 2020) | ||
14-77025670-G-C | Uncertain significance (Nov 27, 2023) | |||
14-77025670-GC-G | IRF2BPL-related disorder | Pathogenic/Likely pathogenic (May 20, 2022) | ||
14-77025672-C-G | Uncertain significance (Jan 24, 2023) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
IRF2BPL | protein_coding | protein_coding | ENST00000238647 | 1 | 4147 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.836 | 0.164 | 0 | 0 | 0 | 0 | 0.00 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 0.734 | 377 | 419 | 0.899 | 0.0000220 | 4934 |
Missense in Polyphen | 29 | 34.784 | 0.83372 | 362 | ||
Synonymous | -9.69 | 372 | 198 | 1.88 | 0.0000116 | 1728 |
Loss of Function | 3.42 | 3 | 19.1 | 0.157 | 8.70e-7 | 216 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.00 | 0.00 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.00 | 0.00 |
Finnish | 0.00 | 0.00 |
European (Non-Finnish) | 0.00 | 0.00 |
Middle Eastern | 0.00 | 0.00 |
South Asian | 0.00 | 0.00 |
Other | 0.00 | 0.00 |
dbNSFP
Source:
- Function
- FUNCTION: May contribute to the control of female reproductive function (By similarity). May play a role in gene transcription by transactivating GNRH1 promoter and repressing PENK promoter. {ECO:0000250}.;
Recessive Scores
- pRec
- 0.112
Haploinsufficiency Scores
- pHI
- 0.696
- hipred
- Y
- hipred_score
- 0.762
- ghis
- 0.504
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- N
- gene_indispensability_score
- 0.114
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Irf2bpl
- Phenotype
Gene ontology
- Biological process
- negative regulation of transcription by RNA polymerase II;positive regulation of transcription by RNA polymerase II;development of secondary female sexual characteristics
- Cellular component
- extracellular space;nucleus;nucleoplasm
- Molecular function
- RNA polymerase II regulatory region sequence-specific DNA binding;DNA-binding transcription activator activity, RNA polymerase II-specific;molecular_function;metal ion binding